Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer

European Journal of Cancer

Volumn 50, Issue 4, 2014, Pages 765-773

  Rietbergen, Michelle M ^a   Martens De Kemp, Sanne R ^a   Bloemena, Elisabeth ^a   Witte, Birgit I ^a   Brink, Arjen ^a   Baatenburg De Jong, Robert J ^b   Leemans, C René ^a   Braakhuis, Boudewijn J M ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cancer stem cell; CD98; Human papillomavirus (HPV); Oropharyngeal cancer; p16; Survival

Indexed keywords

CANCER STEM CELL; CD98; HUMAN PAPILLOMAVIRUS (HPV); OROPHARYNGEAL CANCER; P16; SURVIVAL;

ALPHAPAPILLOMAVIRUS; ANTIGENS, CD44; ANTIGENS, CD98; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894051025     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.11.010     Document Type: Article

References (28)

1. C.R. Leemans, B.J. Braakhuis, and R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
2. W.H. Westra The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management Head Neck Pathol 6 Suppl. 1 2012 S48 S54
3. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
4. C. Fakhry, W.H. Westra, and S. Li et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
5. R.J. Kimple, M.A. Smith, and G.C. Blitzer et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer Cancer Res 73 2013 4791 4800
6. W.C. Spanos, P. Nowicki, and D.W. Lee et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer Arch Otolaryngol Head Neck Surg 135 2009 1137 1146
7. M.C. de Jong, J. Pramana, and J.E. van der Wal et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer Clin Cancer Res 16 2010 5329 5338
8. S. Bao, Q. Wu, and R.E. McLendon et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
9. M.E. Prince, R. Sivanandan, and A. Kaczorowski et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
10. D. Lindquist, A. Ahrlund-Richter, M. Tarjan, T. Tot, and T. Dalianis Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer Anticancer Res 32 2012 153 161
11. S.R. Martens-de Kemp, A. Brink, and M. Stigter-van Walsum et al. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties Stem Cell Res 10 2013 477 488
12. S. Esseghir, J.S. Reis-Filho, and A. Kennedy et al. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts J Pathol 210 2006 420 430
13. M. Ichinoe, T. Mikami, and T. Yoshida et al. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions Pathol Int 61 2011 281 289
14. H. Imai, K. Kaira, and N. Oriuchi et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer Anticancer Res 30 2010 4819 4828
15. K. Kaira, N. Oriuchi, and H. Imai et al. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung Cancer Sci 100 2009 248 254
16. K. Kaira, T. Takahashi, and M. Abe et al. CD98 expression is associated with the grade of malignancy in thymic epithelial tumors Oncol Rep 24 2010 861 867
17. T. Sakata, G. Ferdous, and T. Tsuruta et al. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer Pathol Int 59 2009 7 18
18. A.L. Tang, S.J. Hauff, and J.H. Owen et al. UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line Head Neck 34 2012 1480 1491
19. M.M. Rietbergen, C.R. Leemans, and E. Bloemena et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in The Netherlands as assessed by a validated test algorithm Int J Cancer 132 2013 1565 1571
20. M.M. Rietbergen, R.H. Brakenhoff, and E. Bloemena et al. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials Ann Oncol 24 2013 2740 2745
21. N.L. Van Hal, G.A. van Dongen, M. Stigter-van Walsum, G.B. Snow, and R.H. Brakenhoff Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma Int J Cancer 82 1999 837 845
22. S.P. Hong, J. Wen, S. Bang, S. Park, and S.Y. Song CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells Int J Cancer 125 2009 2323 2331
23. J.N. Rich Cancer stem cells in radiation resistance Cancer Res 67 2007 8980 8984
24. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
25. C. Herold-Mende, S. Seiter, and A.I. Born et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck J Pathol 179 1996 66 73
26. B. Mack, and O. Gires CD44s and CD44v6 expression in head and neck epithelia PLoS One 3 2008 e3360 e3367
27. T. Soukka, M. Salmi, and H. Joensuu et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells Cancer Res 57 1997 2281 2289
28. H.J. van Zeeburg, V. van Beusechem, and A. Huizenga et al. Adenovirus retargeting to surface expressed antigens on oral mucosa J Gene Med 12 2010 365 376